Stage 7 has lasted almost six months. We devoted this time to the implementation of large-scale technical and legal tasks, which allowed us to achieve the planned results in accordance with the roadmap. Now we are ready to take the next step towards creating and launching our first product, CGM FLY, to the market.
Key events and achievements of stage seven:
Building up intellectual property
- 7 patents for unique developments have been obtained.
- Another 12 patent applications have been filed and will be registered by the end of 2024.
Product design
- Professional design for CGM FLY has been developed in one of the world's leading industrial design studios, Art. Lebedev Studio.
Expanding payment options
- New payment systems have been added, including bank card payments.
International scale-up
- National representatives have been appointed:
- Zongo Moumouni (Burkina Faso).
- Ibrahim MOHAMED (Benin).
- The first conference has been held in India as well as a series of regular meetings and activities in Africa (Burkina Faso, Côte d'Ivoire, Cameroon, Benin).
Legal framework
- MLC TECH SYSTEMS has been registered in India.
- Key officials have been appointed:
* Mr. Kiran Jeet Singh, CEO and co-founder of the Indian company.
* Octave ASSOGBA, Member of the African Zone Development Board of Directors.
Welcoming the new participants
- A Welcome package with special terms and conditions is available for new registrations.
Publicity and transparency of the project
- A conference led by the CEO of the MLC project Ivan Saltanov and its co-founders with the national representatives of the project has been held. A conference was held in Dubai including a presentation of the project, interviews and a tour of the company's office in Meydan Zone.
- Representatives from India, Vietnam, Nigeria and Côte d'Ivoire have visited the Moscow office and laboratory of InnoBioSystems.
Some stage 7 statistics:
4,220 new investors, total number of investors in the project: 9,550.
15,000 new registrations, total number of registrations in the project: 59,500.
1,650 million shares sold with a total value of $ 3.7 million, total liabilities in active installment plans: $ 8.1 million.
Received payments on purchased packages: $ 1,905,000, $ 4.215 million worth of total payments received.
Participants from one more country joined the project. Now there are 170 countries participating in the project.
At this stage, we have scrutinized the legal setup, providing a transparent structure to attract investment globally. The accumulated intellectual property continues to grow, strengthening the project's standing.
Join a promising biotech project by MLC and be part of an innovative future!
